Jonathan D. Proto
Impact in
- Immunology top 5%
- Immune cells in cancer
- Phagocytosis and Immune Regulation
- Atherosclerosis and Cardiovascular Diseases
- Neurology top 5%
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
- Genetics 8
- Mesenchymal stem cell research 6
- Chronic Lymphocytic Leukemia Research 2
-
- Muscle Physiology and Disorders 7
- Co-authors
- Ira Tabas (4 shared papers)George Kuriakose (3 shared papers)Erdi Sözen (3 shared papers)Manikandan Subramanian (3 shared papers)Christina C. Rymond (2 shared papers)Amanda C. Doran (2 shared papers)Matthew Spite (1 shared paper)Gabrielle Fredman (1 shared paper)
- Journals
- Neurology (2 papers)Cell Death and Disease (2 papers)Human Molecular Genetics (1 paper)Molecular Therapy (1 paper)Metabolism (1 paper)
- Partner nations
- United StatesTürkiyeUnited Kingdom
In The Last Decade
Jonathan D. Proto
21 papers receiving 1.4k citations
Jonathan D. Proto's Hit Papers
Peers
Comparison fields: 5 of 98
- Immunology 475
- Neurology 143
- Genetics 172
- Biochemistry 97
- Nutrition and Dietetics 157
Countries citing papers authored by Jonathan D. Proto
This map shows the geographic impact of Jonathan D. Proto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan D. Proto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan D. Proto more than expected).
Fields of papers citing papers by Jonathan D. Proto
This network shows the impact of papers produced by Jonathan D. Proto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan D. Proto. The network helps show where Jonathan D. Proto may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan D. Proto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques Hit paper breakdown → | 2016 | 340 |
| 2 | 2018 | 335 | |
| 3 | 2012 | 204 | |
| 4 | 2020 | 106 | |
| 5 | 2011 | 52 | |
| 6 | 2014 | 50 | |
| 7 | 2014 | 50 | |
| 8 | 2018 | 49 | |
| 9 | 2020 | 36 | |
| 10 | 2012 | 35 | |
| 11 | 2015 | 35 | |
| 12 | 2013 | 29 | |
| 13 | 2022 | 12 | |
| 14 | 2020 | 12 | |
| 15 | 2016 | 10 | |
| 16 | 2017 | 9 | |
| 17 | 2014 | 7 | |
| 18 | 2012 | 1 | |
| 19 | 2014 | 1 | |
| 20 | 2013 | 1 |
About Jonathan D. Proto
Jonathan D. Proto is a scholar working on Genetics, Molecular Biology, Immunology, Epidemiology and Surgery, having authored 22 papers that have together received 1.4k indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (7 papers), Mesenchymal stem cell research (6 papers), Immune cells in cancer (4 papers), Immune Cell Function and Interaction (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), Architecture and Computational Design (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Phagocytosis and Immune Regulation (2 papers). The work is most often cited by research in Immunology (475 citations), Neurology (143 citations), Genetics (172 citations), Biochemistry (97 citations) and Nutrition and Dietetics (157 citations). Jonathan D. Proto has collaborated with scholars based in United States, Türkiye and United Kingdom. Frequent co-authors include Ira Tabas, George Kuriakose, Erdi Sözen, Manikandan Subramanian, Christina C. Rymond, Amanda C. Doran, Matthew Spite, Gabrielle Fredman, David Jones and Romain A. Colas. Their work appears in journals such as Neurology, Cell Death and Disease, Human Molecular Genetics, Molecular Therapy and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.